Sionna Therapeutics SION
NASDAQ SION
$3.73 +0.03 (+0.81%)
As of: Nov 11, 2026 · 9:56 AM EST

Sionna Therapeutics (SION) Return on Equity [ROE] (2025 - 2026)

Updated

Sionna Therapeutics (SION) posted Return on Equity [ROE] of -35.18% for Q2 2026, down 12.94 percentage points from -22.24% a year earlier and down 6.34 percentage points from the prior quarter.

Analysis

Sionna Therapeutics (SION) Return on Equity [ROE] (2025 - 2026) Analysis & Trends

For FY2025, Sionna Therapeutics' Return on Equity [ROE] came in at -105.77%.

  • The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q1 2025.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -28.84% (Q1 2026), -24.08% (Q4 2025) and -21.66% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Sionna Therapeutics 167.27 Mn -720.38 Mn - -43.72%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -43.72%
Jun 30, 2026 -35.39%
Mar 31, 2026 -28.89%
Dec 31, 2025 -23.90%
Sep 30, 2025 -21.59%
Jun 30, 2025 -21.94%
Mar 31, 2025 -70.21%
API Access

Sionna Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SION&period=max&api_key=YOUR_API_KEY